Advanced

Magnetic Resonance Imaging in Parkinsons's disease and related disoders

Surova, Yulia LU (2018)
Abstract (Swedish)
Objectives: To identify diagnostic and prognostic biomarkers in the cerebral white (WM) and the deep grey matter (GM) in patients with Parkinson’s disease (PD) and atypical parkinsonian syndromes (APS) using magnetic resonance imaging (MRI).
Methods: Patients with a clinical diagnosis of PD, multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) were included in the study. Patients and controls underwent standardized clinical assessment and testing regarding motor and cognitive function. All patients underwent MRI, including Diffusion tensor imaging (DTI), Diffusion tensor tractography (DTT), Diffusion kurtosis imaging (DKI), Neurite density Imaging (NDI), morphometric analyses and Susceptibility weighted imaging... (More)
Objectives: To identify diagnostic and prognostic biomarkers in the cerebral white (WM) and the deep grey matter (GM) in patients with Parkinson’s disease (PD) and atypical parkinsonian syndromes (APS) using magnetic resonance imaging (MRI).
Methods: Patients with a clinical diagnosis of PD, multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) were included in the study. Patients and controls underwent standardized clinical assessment and testing regarding motor and cognitive function. All patients underwent MRI, including Diffusion tensor imaging (DTI), Diffusion tensor tractography (DTT), Diffusion kurtosis imaging (DKI), Neurite density Imaging (NDI), morphometric analyses and Susceptibility weighted imaging (SWI).
Results:
In paper I we assessed both global and regional changes in larger cerebral WM tracts of patients with PD, MSA-P, and PSP, employing DTT. We found that the anterior portion of the corpus callosum is a promising region for detection of neurodegenerative changes in patients with PSP, as well as for differential diagnosis between PSP and PD.
In paper II we investigated the disease specific changes in the basal ganglia, the thalamus, the pons, the midbrain, and the dentato-rubro-thalamic tract (DRTT) of patients with PD, MSA-P, and PSP, using DTI and morphometric analyses. We found that patients with PSP, but not PD or MSA-P, exhibit signs of structural abnormalities in the thalamus and in the DRTT. We also found that these disease-specific changes are associated with disease stage and impaired motor function.
In paper III we investigated if changes in subcortical nuclei, brainsteam and WM tracts measured by DKI and NDI could differentiate between PD and controls, and between phenotypes, such as postural instability gait difficulty (PIGD) and tremor dominant (TD) PD. We found that patients with PD exhibit diffusion MRI (dMRI) changes in the putamen, the thalamus, and the superior longitudinal fasciculus associated with worse disease severity. However, the dMRI changes were not sufficiently specific to improve the diagnostic work-up of PD.
In paper IV we investigated longitudinal dMRI measures over a two year period in PD. The study indicates that in PD microstructural changes in the putamen occur selectively over a two-year period and can be detected with DKI.
In paper V we evaluated the use of quantitative susceptibility mapping (QSM) for clinical diagnostics in PD, PSP and MSA. PSP showed higher susceptibility in the globus pallidus, substantia nigra, red nucleus and dentate nucleus compared to all other groups, and higher putaminal susceptibility compared to PD and controls. MSA showed higher putaminal susceptibility compared to PD and controls, and higher susceptibility in the substantia nigra and dentate nucleus compared to PD. Discriminant analysis between PSP and all other groups combined, a sensitivity of 91% and specificity of 97% was achieved. Using all regions to separate MSA from all other groups combined, a sensitivity of 70% and specificity of 93% was noted. We also found correlations between disease severity measured by motor part of unified PD raiting scale (UPDRS-III) and putaminal susceptibility in PD. (Less)
Please use this url to cite or link to this publication:
author
supervisor
opponent
  • professor Forsgren, Lars, Umeå
organization
alternative title
Magnetisk resonanstomografi in Parinsons sjukdom och relaterade tillstånd
publishing date
type
Thesis
publication status
published
keywords
Mr Imaging, DTI, Parkinson's disease, Progressive supranuclear palsy, Multiple system atrophy
pages
98 pages
publisher
Lund University, Faculty of Medicine
defense location
Föreläsningssal 4, Centralblocket, Universitetssjukhuset i Lund
defense date
2018-03-23 13:00
ISBN
978-91-7619-590-1
language
English
LU publication?
yes
id
d1a1b232-02f6-414e-93c3-623414110afc
date added to LUP
2018-02-19 12:45:27
date last changed
2018-05-29 12:10:48
@phdthesis{d1a1b232-02f6-414e-93c3-623414110afc,
  abstract     = {Objectives: To identify diagnostic and prognostic biomarkers in the cerebral white (WM) and the deep grey matter (GM) in patients with Parkinson’s disease (PD) and atypical parkinsonian syndromes (APS) using magnetic resonance imaging (MRI). <br/>Methods: Patients with a clinical diagnosis of PD, multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) were included in the study. Patients and controls underwent standardized clinical assessment and testing regarding motor and cognitive function. All patients underwent MRI, including Diffusion tensor imaging (DTI), Diffusion tensor tractography (DTT), Diffusion kurtosis imaging (DKI), Neurite density Imaging (NDI), morphometric analyses and Susceptibility weighted imaging (SWI).<br/>Results: <br/>In paper I we assessed both global and regional changes in larger cerebral WM tracts of patients with PD, MSA-P, and PSP, employing DTT. We found that the anterior portion of the corpus callosum is a promising region for detection of neurodegenerative changes in patients with PSP, as well as for differential diagnosis between PSP and PD.<br/>In paper II we investigated the disease specific changes in the basal ganglia, the thalamus, the pons, the midbrain, and the dentato-rubro-thalamic tract (DRTT) of patients with PD, MSA-P, and PSP, using DTI and morphometric analyses. We found that patients with PSP, but not PD or MSA-P, exhibit signs of structural abnormalities in the thalamus and in the DRTT. We also found that these disease-specific changes are associated with disease stage and impaired motor function.<br/>In paper III we investigated if changes in subcortical nuclei, brainsteam and WM tracts measured by DKI and NDI could differentiate between PD and controls, and between phenotypes, such as postural instability gait difficulty (PIGD) and tremor dominant (TD) PD. We found that patients with PD exhibit diffusion MRI (dMRI) changes in the putamen, the thalamus, and the superior longitudinal fasciculus associated with worse disease severity. However, the dMRI changes were not sufficiently specific to improve the diagnostic work-up of PD.<br/>In paper IV we investigated longitudinal dMRI measures over a two year period in PD. The study indicates that in PD microstructural changes in the putamen occur selectively over a two-year period and can be detected with DKI.<br/>In paper V we evaluated the use of quantitative susceptibility mapping (QSM) for clinical diagnostics in PD, PSP and MSA. PSP showed higher susceptibility in the globus pallidus, substantia nigra, red nucleus and dentate nucleus compared to all other groups, and higher putaminal susceptibility compared to PD and controls. MSA showed higher putaminal susceptibility compared to PD and controls, and higher susceptibility in the substantia nigra and dentate nucleus compared to PD. Discriminant analysis between PSP and all other groups combined, a sensitivity of 91% and specificity of 97% was achieved. Using all regions to separate MSA from all other groups combined, a sensitivity of 70% and specificity of 93% was noted. We also found correlations between disease severity measured by motor part of unified PD raiting scale (UPDRS-III) and putaminal susceptibility in PD.},
  author       = {Surova, Yulia},
  isbn         = {978-91-7619-590-1},
  keyword      = {Mr Imaging,DTI,Parkinson's disease,Progressive supranuclear palsy,Multiple system atrophy },
  language     = {eng},
  month        = {02},
  pages        = {98},
  publisher    = {Lund University, Faculty of Medicine},
  school       = {Lund University},
  title        = {Magnetic Resonance Imaging in Parkinsons's disease and related disoders},
  year         = {2018},
}